非酒精性脂肪性肝炎
脂肪性肝炎
甲状腺功能不全
兴奋剂
纤维化
医学
胃肠病学
激素
内分泌学
脂肪肝
内科学
受体
非酒精性脂肪肝
疾病
标识
DOI:10.58347/tml.2024.1701a
摘要
Resmetirom (Rezdiffra – Madrigal), a thyroid hormone receptor-beta agonist, has received accelerated approval from the FDA for treatment of noncirrhotic nonalcoholic steatohepatitis (NASH) with moderate to advanced fibrosis in adults.
科研通智能强力驱动
Strongly Powered by AbleSci AI